Disparities in incidence and mortality of pancreatic cancer in the world

Authors

  • Yousef Khani Alborz University of Medical Sciences, Karaj, Iran
  • Masoumeh Arabsalmani Health Promotion Research Center, Department of Epidemiology and Biostatistics, School of Public Health, Zahedan University of Medical Sciences, Zahedan, Iran
  • Reza Pakzad Student Research committee, Ilam University of Medical Sciences, Ilam, Iran
  • Mahshid Ghoncheh Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Abdollah Mohammadian-Hafshejani Department of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
  • Hamid Salehiniya Zabol University of Medical Sciences, Zabol, Iran; Department of Epidemiology and Biostatistics , Tehran University of medical sciences, Tehran, Iran

DOI:

https://doi.org/10.15419/bmrat.v5i02.415

Keywords:

Disparities, Incidence, Mortality, Pancreatic cancer, World

Abstract

Background: Pancreatic cancer (PC) is as the twelfth most frequent cancer and the seventh most important cause of mortality by reason of cancer in the world. Being informed about the incidence and mortality of this cancer and the potential role of development is useful in health policy. The aim of this research is investigating disparities in the incidence and mortality of PC in the world countries in the year 2012.

Methods: This study was an ecologic study in the World for assessing the correlation between Human Development Index (HDI) and its details (Gross national income (GNI) per capita, average years of schooling and life expectancy at birth) with age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of PC.

Results: In total, 337872 new cases of PC occurred in 2012 around the world , that 178116 and 159711 cases take happen in men and women respectively, also at the same year 330391 deaths of PC occurred ,that 173,827 and 156564 cases were in men and women. In assessment the relationship between HDI and ASIR and ASMR of PC there is significant positive correlation equal to 0.767 (p <0.001) between HDI and ASIR of PC, and a significant positive correlation equal to 0.776 (p <0.001) between HDI and ASMR of PC.

Conclusion: The incidence and mortality of PC has a significant positive correlation with the Human Development Index.

 

Author Biography

  • Hamid Salehiniya, Zabol University of Medical Sciences, Zabol, Iran; Department of Epidemiology and Biostatistics , Tehran University of medical sciences, Tehran, Iran
    alesaleh70@yahoo.com

References

Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., & Cho, H. (2010). SEER cancer statistics review, 1975-2007 (p. 7). Bethesda, MD: National Cancer Institute.
Arabsalmani, M., Mohammadian-Hafshejani, A., Ghoncheh, M., Hadadian, F., Towhidi, F., Vafaee, K., & Salehiniya, H. (2017). Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. Journal of Nephropathology, 6(1), 30–42. https://doi.org/10.15171/jnp.2017.06 PMID:28042551
Bakens, M., van Gestel, Y., Bongers, M., Lemmens, V., & de Hingh, I. (2015). Socio-economic status influences chance of undergoing surgical treatment for pancreatic cancer in The Netherlands. Pancreatology, 15(3), S101. https://doi.org/10.1016/j.pan.2015.05.366
Baxter, N. N., Whitson, B. A., & Tuttle, T. M. (2007). Trends in the treatment and outcome of pancreatic cancer in the United States. Annals of Surgical Oncology, 14(4), 1320–1326. https://doi.org/10.1245/s10434-006-9249-8 PMID:17225980
Berman, P. M. (1995). Gastroenterology: Clinical Science and Practice. Journal of the American Medical Association, 274(1), 79–79. https://doi.org/10.1001/jama.1995.03530010093042 PMID:7996658
Bonelli, L., Aste, H., Bovo, P., Cavallini, G., Felder, M., Gusmaroli, R., . . . Pugliese, V. (2003). Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in northern Italy. Pancreas, 27(2), 143–149. https://doi.org/10.1097/00006676-200308000-00007 PMID:12883263
Bosetti, C., Lucenteforte, E., Silverman, D. T., Petersen, G., Bracci, P. M., Ji, B. T., . . . La Vecchia, C. (2012). Cigarette smoking and pancreatic cancer: An analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of Oncology : Official Journal of the European Society for Medical Oncology, 23(7), 1880–1888. https://doi.org/10.1093/annonc/mdr541 PMID:22104574
Bramhall, S. R., Allum, W. H., Jones, A. G., Allwood, A., Cummins, C., & Neoptolemos, J. P. (1995). Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study. British Journal of Surgery, 82(1), 111–115. https://doi.org/10.1002/bjs.1800820137 PMID:7881926
Bray, F. (2014). Transitions in human development and the global cancer burden. World cancer report, 54-68.
Bray, F., Ren, J. S., Masuyer, E., & Ferlay, J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer, 132(5), 1133–1145. https://doi.org/10.1002/ijc.27711 PMID:22752881
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012). Global cancer transitions according to the Human Development Index (2008-2030): A population-based study. The Lancet. Oncology, 13(8), 790–801. https://doi.org/10.1016/S1470-2045(12)70211-5 PMID:22658655
Curado, M.-P., Edwards, B., Shin, H. R., Storm, H., Ferlay, J., Heanue, M., & Boyle, P. (2007). Cancer incidence in five continents (Vol. IX). IARC Press, International Agency for Research on Cancer.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2016). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 2/2/2016.
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W.W., Comber, H., Forman, D. and Bray, F. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 1374–1403. https://doi.org/10.1016/j.ejca.2012.12.027 PMID:23485231
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386. https://doi.org/10.1002/ijc.29210 PMID:25220842
Forman, D, Ferlay, J, Stewart, BW, & Wild, CP. (2014). The global and regional burden of cancer. World cancer report, 16-53.
Franceschi, S., & Wild, C. P. (2013). Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention. Molecular Oncology, 7(1), 1–13. https://doi.org/10.1016/j.molonc.2012.10.010 PMID:23218182
Fuchs, C.S., Colditz, G.A., Stampfer, M.J., Giovannucci, E.L., Hunter, D.J., Rimm, E.B., Willett, W.C. and Speizer, F.E. (1996). A prospective study of cigarette smoking and the risk of pancreatic cancer. Archives of Internal Medicine, 156(19), 2255–2260. https://doi.org/10.1001/archinte.1996.00440180119015 PMID:8885826
Ghadirian, P., Thouez, J. P., & PetitClerc, C. (1991). International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detection and Prevention, 15(5), 357–362. PMID:1751946
Ghoncheh, M., Mohammadian, M., Mohammadian-Hafshejani, A., & Salehiniya, H. (2016). The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia. Annals of Global Health, 82(5), 726–737. https://doi.org/10.1016/j.aogh.2016.10.004 PMID:28283123
Gold, E. B., & Goldin, S. B. (1998). Epidemiology of and risk factors for pancreatic cancer. Surgical Oncology Clinics of North America, 7(1), 67–91. PMID:9443987
Greene, Michael F, Creasy, Robert K, Resnik, Robert, Iams, Jay D, Lockwood, Charles J, & Moore, Thomas. (2008). Creasy and Resnik's maternal-fetal medicine: principles and practice: Elsevier Health Sciences.
Hartwig, W., Hackert, T., Hinz, U., Hassenpflug, M., Strobel, O., Büchler, M. W., & Werner, J. (2009). Multivisceral resection for pancreatic malignancies: Risk-analysis and long-term outcome. Annals of Surgery, 250(1), 81–87. https://doi.org/10.1097/SLA.0b013e3181ad657b PMID:19561478
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., . . . Li, D. (2007). Risk factors for pancreatic cancer: Case-control study. The American Journal of Gastroenterology, 102(12), 2696–2707. https://doi.org/10.1111/j.1572-0241.2007.01510.x PMID:17764494
Hassanipour-Azgomi, S., Mohammadian-Hafshejani, A., Ghoncheh, M., Towhidi, F., Jamehshorani, S., & Salehiniya, H. (2016). Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate International, 4(3), 118–124. https://doi.org/10.1016/j.prnil.2016.07.001 PMID:27689070
Hippisley-Cox, J., & Coupland, C. (2012). Identifying patients with suspected pancreatic cancer in primary care: Derivation and validation of an algorithm. The British Journal of General Practice, 62(594), e38–e45. https://doi.org/10.3399/bjgp12X616355 PMID:22520674
Howlader, N., Noone, A. M., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., & Altekruse, S. F. (2011). Surveillance, Epidemiology, and End Results Program. Bethesda: National Cancer Institute.
Hu, Q.-D., Zhang, Q., Chen, W., Bai, X.-L., & Liang, T.-B. (2013). Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers. World Journal of Gastroenterology, 19(32), 5261–5270. https://doi.org/10.3748/wjg.v19.i32.5261 PMID:23983428
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: a Cancer Journal for Clinicians, 61(2), 69–90. https://doi.org/10.3322/caac.20107 PMID:21296855
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention, 19(8), 1893–1907. https://doi.org/10.1158/1055-9965.EPI-10-0437 PMID:20647400
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: a Cancer Journal for Clinicians, 60(5), 277–300. https://doi.org/10.3322/caac.20073 PMID:20610543
Jemal, A., Simard, E. P., Xu, J., Ma, J., & Anderson, R. N. (2013). Selected cancers with increasing mortality rates by educational attainment in 26 states in the United States, 1993-2007. Cancer Causes & Control, 24(3), 559–565. https://doi.org/10.1007/s10552-012-9993-y PMID:22729932
Kanavos, Panos. (2006). The rising burden of cancer in the developing world. Annals of oncology, 17(suppl 8), viii15-viii23. https://doi.org/10.1093/annonc/mdl983
Keane, M. G., Horsfall, L. J., Rait, G., & Pereira, S. P. (2014). Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care. PLoS One, 9(9), e108498. https://doi.org/10.1371/journal.pone.0108498 PMID:25268478
Keyghobadi, N., Rafiemanesh, H., Mohammadian-Hafshejani, A., Enayatrad, M., & Salehiniya, H. (2015). Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran. Asian Pacific Journal of Cancer Prevention, 16(4), 1409–1413. https://doi.org/10.7314/APJCP.2015.16.4.1409 PMID:25743807
Larsson, S. C., Permert, J., Håkansson, N., Näslund, I., Bergkvist, L., & Wolk, A. (2005). Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. British Journal of Cancer, 93(11), 1310–1315. https://doi.org/10.1038/sj.bjc.6602868 PMID:16288300
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Jr., Perrault, J., & Whitcomb, D. C., & the International Hereditary Pancreatitis Study Group. (1997). Hereditary pancreatitis and the risk of pancreatic cancer. Journal of the National Cancer Institute, 89(6), 442–446. https://doi.org/10.1093/jnci/89.6.442 PMID:9091646
Lowenfels, A. B., & Maisonneuve, P. (2006). Epidemiology and risk factors for pancreatic cancer. Best Practice & Research. Clinical Gastroenterology, 20(2), 197–209. https://doi.org/10.1016/j.bpg.2005.10.001 PMID:16549324
Malik, K. (2013). Human development report 2013. The rise of the south: Human progress in a diverse world. The Rise of the South: Human Progress in a Diverse World (March 15, 2013) UNDP-HDRO Human Development Reports. 2013.
Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C., & Negri, E. (2013). European cancer mortality predictions for the year 2013. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 24(3), 792–800. https://doi.org/10.1093/annonc/mdt010 PMID:23402763
Mathers, C. D., Fat, D. M., Inoue, M., Rao, C., & Lopez, A. D. (2005). Counting the dead and what they died from: An assessment of the global status of cause of death data. Bulletin of the World Health Organization, 83(3), 171–177. PMID:15798840
Michaud, D. S. (2004). Epidemiology of pancreatic cancer. Minerva Chirurgica, 59(2), 99–111. PMID:15238885
Mohammadian, M., Ghafari, M., Khosravi, B., Salehiniya, H., Aryaie, M., Bakeshei, F. A., & Mohammadian-Hafshejani, A. (2017). Variations in the Incidence and Mortality of Ovarian Cancer and Their Relationship with the Human Development Index in European Countries in 2012. Biomedical Research and Therapy, 4(08), 1541–1557. https://doi.org/10.15419/bmrat.v4i08.228
Mohammadian, M., Soroush, A., Mohammadian-Hafshejani, A., Towhidi, F., Hadadian, F., & Salehiniya, H. (2016). Incidence and Mortality of Liver Cancer and Their Relationship with Development in Asia. Asian Pacific Journal of Cancer Prevention, 17(4), 2041–2047. https://doi.org/10.7314/APJCP.2016.17.4.2041 PMID:27221893
Muniraj, T., Jamidar, P. A., & Aslanian, H. R. (2013). Pancreatic cancer: A comprehensive review and update. Disease-a-Month, 59(11), 368–402. https://doi.org/10.1016/j.disamonth.2013.08.001 PMID:24183261
Muscat, J. E., Stellman, S. D., Hoffmann, D., & Wynder, E. L. (1997). Smoking and pancreatic cancer in men and women. Cancer Epidemiology, Biomarkers & Prevention, 6(1), 15–19. PMID:8993792
Neesse, A., Michl, P., Frese, K.K., Feig, C., Cook, N., Jacobetz, M.A., Lolkema, M.P., Buchholz, M., Olive, K.P., Gress, T.M. and Tuveson, D.A. (2011). Stromal biology and therapy in pancreatic cancer. Gut, 60(6), 861-868.
Neoptolemos, J.P., Stocken, D.D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M.J., Gallinger, S., Mariette, C. and Wente, M.N. (2010). Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial. Journal of the American Medical Association, 304(10), 1073–1081. https://doi.org/10.1001/jama.2010.1275 PMID:20823433
Neoptolemos, J. P., Dunn, J. A., Stocken, D. D., Almond, J., Link, K., Beger, H., . . . Büchler, M. W., & the European Study Group for Pancreatic Cancer. (2001). Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet, 358(9293), 1576–1585. https://doi.org/10.1016/S0140-6736(01)06651-X PMID:11716884
Organization, World Health. (2000). The world health report 2000: health systems: improving performance: World Health Organization.
Pakzad, R., Ghoncheh, M., Pournamdar, Z., Pakzad, I., Momenimovahed, Z., Salehiniya, H., & Makhsosi, B. R. (2016). Spatial Analysis of Skin Cancer Incidence in Iran. Asian Pacific Journal of Cancer Prevention, 17(sup3, S3), 33–37. https://doi.org/10.7314/APJCP.2016.17.S3.33 PMID:27165204
Pakzad, R., Mohammadian-Hafshejani, A., Ghoncheh, M., Pakzad, I., & Salehiniya, H. (2015a). The incidence and mortality of lung cancer and their relationship to development in Asia. Translational Lung Cancer Research, 4(6), 763–774. https://doi.org/10.3978/j.issn.2218-6751.2015.12.01 PMID:26798586
Pakzad, R., Mohammadian-Hafshejani, A., Ghoncheh, M., Pakzad, I., & Salehiniya, H. (2015b). The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate International, 3(4), 135–140. https://doi.org/10.1016/j.prnil.2015.09.001 PMID:26779461
Pakzad, R., Mohammadian-Hafshejani, A., Mohammadian, M., Pakzad, I., Safiri, S., Khazaei, S., & Salehiniya, H. (2015). Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia. Asian Pacific Journal of Cancer Prevention, 16(16), 7365–7374. https://doi.org/10.7314/APJCP.2015.16.16.7365 PMID:26514538
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: a Cancer Journal for Clinicians, 55(2), 74–108. https://doi.org/10.3322/canjclin.55.2.74 PMID:15761078
Pourhoseingholi, M. A., Vahedi, M., & Baghestani, A. R. (2014). Burden of gastrointestinal cancer in Asia; an overview. Gastroenterology and Hepatology from Bed To Bench, 1(1). PMID:25584172
Rafiemanesh, H., Mohammadian-Hafshejani, A., Ghoncheh, M., Sepehri, Z., Shamlou, R., Salehiniya, H., . . . Makhsosi, B. R. (2016). Incidence and mortality of colorectal cancer and relationships with the human development index across the world. Asian Pacific journal of cancer prevention. APJCP, 17(5), 2465–2473. PMID:27268615
Ravallion, M. (1997). Good and bad growth: The human development reports. World Development, 25(5), 631–638. https://doi.org/10.1016/S0305-750X(96)00141-6
Razi, Saeid, Ghoncheh, Mahshid, Mohammadian-Hafshejani, Abdollah, Aziznejhad, Hojjat, Mohammadian, Mahdi, & Salehiniya, Hamid. (2016). The incidence and mortality of ovarian cancer and their relationship with the Human Development Index in Asia. ecancermedicalscience, 10.
Ryu, J. K., Hong, S. M., Karikari, C. A., Hruban, R. H., Goggins, M. G., & Maitra, A. (2010). Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 10(1), 66–73. https://doi.org/10.1159/000231984 PMID:20332664
Sasson, A. R., Hoffman, J. P., Ross, E. A., Kagan, S. A., Pingpank, J. F., & Eisenberg, B. L. (2002). En bloc resection for locally advanced cancer of the pancreas: Is it worthwhile? Journal of Gastrointestinal Surgery, 6(2), 147–157. https://doi.org/10.1016/S1091-255X(01)00063-4 PMID:11992799
Schwartz, G. G., & Reis, I. M. (2000). Is cadmium a cause of human pancreatic cancer? Cancer Epidemiology, Biomarkers & Prevention, 9(2), 139–145. PMID:10698473
Shuja, M., Farsani, S. I., Salehiniya, H., Khazaei, S., Mohammadian, M., Aryaie, M., ... & Mohammadian-Hafshejani, A. (2017). Assessment the association between liver cancer incidence and mortality rate with human development index in the European countries in 2012. Biomedical Research and Therapy, 4(03), 1185-1197. https://doi.org/10.15419/bmrat.v4i03.156
Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 62(1), 10–29. https://doi.org/10.3322/caac.20138 PMID:22237781
Silverman, D. T., Dunn, J. A., Hoover, R. N., Schiffman, M., Lillemoe, K. D., Schoenberg, J. B., . . .. (1994). Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. Journal of the National Cancer Institute, 86(20), 1510–1516. https://doi.org/10.1093/jnci/86.20.1510 PMID:7932805
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009). Future of cancer incidence in the United States: Burdens upon an aging, changing nation. Journal of Clinical Oncology, 27(17), 2758–2765. https://doi.org/10.1200/JCO.2008.20.8983 PMID:19403886
Society, American Cancer. (2013). Cancer facts and figures 2013: American Cancer Society Atlanta.
Stapley, S., Peters, T. J., Neal, R. D., Rose, P. W., Walter, F. M., & Hamilton, W. (2012). The risk of pancreatic cancer in symptomatic patients in primary care: A large case-control study using electronic records. British Journal of Cancer, 106(12), 1940–1944. https://doi.org/10.1038/bjc.2012.190 PMID:22617126
Stats, F. (2012). An interactive tool for access to SEER cancer statistics. Surveillance Research Program. National Cancer Institute.
Tiyuri, A., Mohammadian-Hafshejani, A., Iziy, E., Gandomani, H. S., & Salehiniya, H. (2017). The incidence and mortality of lip and oral cavity cancer and its relationship to the 2012 Human Development Index of Asia. Biomedical Research and Therapy, 4(02), 1147–1165. https://doi.org/10.15419/bmrat.v4i02.151
Toriola, A. T., Stolzenberg-Solomon, R., Dalidowitz, L., Linehan, D., & Colditz, G. (2014). Diabetes and pancreatic cancer survival: A prospective cohort-based study. British Journal of Cancer, 111(1), 181–185. https://doi.org/10.1038/bjc.2014.224 PMID:24786605
Valean, S., Acalovschi, M., Diculescu, M., Manuc, M., Goldis, A., Sfarti, C., & Trifan, A. (2015). Mortality in Digestive Cancers, 2012: International Data and Data from Romania. Journal of Gastrointestinal and Liver Diseases; JGLD, 24(4), 507–514. PMID:26697578
Wang, L., Yang, G.-H., Lu, X.-H., Huang, Z.-J., & Li, H. (2003). Pancreatic cancer mortality in China (1991-2000). WJG, 9(8), 1819–1823. https://doi.org/10.3748/wjg.v9.i8.1819 PMID:12918128
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: a Cancer Journal for Clinicians, 54(2), 78–93. https://doi.org/10.3322/canjclin.54.2.78 PMID:15061598

Published

2018-02-26

Issue

Section

Original Research

How to Cite

Disparities in incidence and mortality of pancreatic cancer in the world. (2018). Biomedical Research and Therapy, 5(02), 1986-1999. https://doi.org/10.15419/bmrat.v5i02.415

Similar Articles

71-80 of 299

You may also start an advanced similarity search for this article.